Skip to main content
SpringerLink
Log in

Iron metabolism during infection and neoplasia

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Invasion of the vertebrate host by microorganisms or neoplastic cells triggers a variety of metabolic responses. One of them, the hypoferremic response, is the decrease in serum iron levels. This hypoferremia is observed not only during infections of various etiologies and neoplasia but also during trauma, myocardial infarction, surgery, and inflammation. The hypoferremic response thus appears to be a consistent and predictable biochemical response to pathogenesis. Hypoferremia has been shown to be of great protective value to the host against infection and neoplasia. Suppression of the iron-withholding ability of the host by excess iron is associated with a greater incidence and severity of infection and neoplasia. The potential therapeutic applications of the hypoferremic response are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wrigglesworth JM, Baum H: The Biochemical functions of iron. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp. 29–86

    Google Scholar 

  2. Forth W, Rummel W: Iron absorption. Physiol Rev 53: 724–292, 1973

    Google Scholar 

  3. Wheby MS. Suttle GE, Ford KT: Intestinal absorption of hemoglobin iron. Gastroenterology 58: 647–654, 1970

    Google Scholar 

  4. Bezkorovainy A: Chemistry and biology of iron storage. In: Frieden E (ed) Biochemistry of non-heme iron. Plenum Press, New York, 1980, pp 207–269

    Google Scholar 

  5. Aisen P: The transferrins. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp87–129

    Google Scholar 

  6. Aisen P, Listowsky I: Iron transport and storage proteins. Ann Rev Biochem 49: 357–393, 1980

    Google Scholar 

  7. Romslo I: Intracellular transport of iron. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine, Academic Press, New York, 1980, pp 325–362

    Google Scholar 

  8. Hershko C: Storage iron regulation. Prog Haematol X: 105–148, 1977

    Google Scholar 

  9. Lipschitz DA, Simon MO, Lynch SR, Dugard J, Bothwell TH: Some factors affecting the release of iron from reticulo-endothelial cells. Br J Hematol 21: 289–303, 1971

    Google Scholar 

  10. Harrison PM, Hoy TG, Hoare RJ: Towards a mechanism of iron uptake and release by ferritin molecules. In: Crichton RR (ed) Proteins of iron storage and transport in Biochemistry and Medicine. North Holland, Amsterdam, 1975, pp 271–278

    Google Scholar 

  11. Fillet G, Cook JD, Finch CA: Storage iron kinetics. VII. A biologic model for reticulo-endothelial iron transport. J Clin Invest 53: 1527–1533, 1974

    Google Scholar 

  12. Bothwell TH, Bradlow BA, Jacobs P: Iron metabolism in scurvy with special reference to erythropoiesis. Br J Hematol 10: 50–58, 1964

    Google Scholar 

  13. Wapnick AA, Bothwell TH, Seftel H: The relationship between serum iron levels and ascorbic acid stores in siderotic Bantu. Br J Hematol 19: 271–276, 1970

    Google Scholar 

  14. Frieden E, Hsieh S: Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol 45: 187–236, 1976

    Google Scholar 

  15. Neilands JB: Microbial metabolism of iron. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp 529–572

    Google Scholar 

  16. Light RA, Clegg RA: Metabolism in iron-limited growth. In: Neilands JB (ed) Microbial iron metabolism. Academic Press, New York, 1974, pp 35–64

    Google Scholar 

  17. Hunt J, richards J, Harwood R, Jacob A: The effect of desferroxiamine on fibroblasts and collagen formation in cell cultures. Br J Hematol 41: 69–76, 1979

    Google Scholar 

  18. Weinberg ED: Iron and infection. Microbiol Rev 42: 45–66, 1978

    Google Scholar 

  19. Neilands JB: Microbial iron compounds. Annu Rev Biochem 50: 715–731, 1981

    Google Scholar 

  20. Fernandez-Pol JA: Siderophore-like growth factor synthesis by transformed cells. Microbiology 1983: 313–317, 1983

    Google Scholar 

  21. Fernandez-Pol JA: Peptide and protein complexes of transition metals as Modulators of cellular replication. Int J Nucl Med Biol 8: 231–235, 1981

    Google Scholar 

  22. Brock JH, Rankin MC: Transferrin binding and iron up-take by mouse lymph node cells during transformation in response to concanavalin A. Immunology 43: 393–398, 1981

    Google Scholar 

  23. Frazier JL, Caskey JH, Yoffe M, Seligman PA: Studies of the transferrin receptor on both human reticulocytes and nucleated human cells in culture. J Clin Invest 69: 853–865, 1982

    Google Scholar 

  24. Galbraith GM, Galbraith RM, Faulk WP: Transferrin binding by human lymphoblastoid cell lines and other transformed cells. Cell Immunol 49: 215–222, 1980

    Google Scholar 

  25. Hamilton TA, Wada HG, Sussman HH: Identification of transferrin receptors on the surface of human cultured cells. Proc Natl Acad Sci USA 76: 6406–6410, 1979

    Google Scholar 

  26. Larrick JW, Cresswell P: Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramolec Struct 11: 579–586, 1979

    Google Scholar 

  27. Trowbridge IS, Omary MB: Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78: 3039–3043, 1981

    Google Scholar 

  28. Hu HY, Aisen P: Molecular characteristics of the transferrin receptor complex of the rabbit reticulocyte. J Supramolec Struct 8: 349–360, 1978

    Google Scholar 

  29. Weinberg ED: Iron and neoplasia. Biol Trace El Res 3: 55–80, 1981

    Google Scholar 

  30. Weinberg ED: Iron withholding: a defence against infection and neoplasia. Physiol Rev 64: 65–102

  31. Pekarek RS, Bostian KA, Bartelloni PJ, Celia FM, Beisel WR: The effects of Francisella tularensis infection on iron metabolism in man. Am J Med Sci 258: 14–25, 969

  32. Beamish MR, Jones PA, Trevett D, Evans IH, Jacob A: Iron metabolism in Hodgkin's disease. Br J Cancer 26: 444–452

  33. Beisel WR: Trace elements in infectious processes. Med Clin North Am 60: 831–849, 1976

    Google Scholar 

  34. Schade SG: Normal incorporation of oral iron into intestinal ferritin in inflammation. Proc Soc Exp Biol Med 139: 620–622, 1972

    Google Scholar 

  35. Schade SG: Suppressive effect of endotoxin on erythropoietin-responsive cells in mice. Am J Physiol 231: 73–76, 1976

    Google Scholar 

  36. Hershko C, Cook JD, Finch CA: Storage iron kinetics. VI. The effect of inflammation on iron exchange in the rat. Br J Hematol 28: 67–75, 1974

    Google Scholar 

  37. Cartwright GE, Lee GR: The anemia of chronic disorders. Br J Hematol 21: 147–152, 1971

    Google Scholar 

  38. Beresford CH, Neale RJ, Brooks OG: Iron absorption and pyrexia. Lancet 1: 568–575, 1971

    Google Scholar 

  39. Cortell S, Conrad ME: Effect of endotoxin on iron absorption. Am J Physiol 213: 43–47, 1967

    Google Scholar 

  40. Haurani FI, Green D, Young K: Iron absorption in hypoferremia Am J Med Sci 249: 537–547, 1967

    Google Scholar 

  41. Haurani FI, Burke W, Martinez EJ: Defective reutilization of iron in the anemia of inflammation. J Lab Clin Med 65: 56–571, 1965

    Google Scholar 

  42. Crosby DH: The control of iron balance by the intestinal mucosa. Blood 22: 441–449, 1963

    Google Scholar 

  43. Freirich EJ, Miller A, Emerson CP, Ross JF: The effect of inflammation on the utilization of erythrocyte and transferrin bound radioiron for red cell production. Blood 12: 972–983, 1957

    Google Scholar 

  44. Roeser HP: Iron metabolism in inflammation and malignant disease. In: Jacob A, Worwood M (eds) Iron in Biochemistry and Medicine, Academic Press, New York, 1980, pp 605–640

    Google Scholar 

  45. Van Snick JL, Masson PL, Heremans JF: The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med 140: 1068–1084, 1974

    Google Scholar 

  46. Lee GR: The anemia of chronic disease. Semin Hematol 20: 61–80, 1983

    Google Scholar 

  47. Finkelstein RA, Sciortino CV, McIntosh MA: Role of iron in microbe-host interaction. Rev Infect Dis 5: 759–777, 1983

    Google Scholar 

  48. Noyes WD, Bothwell TH, Finch CA: The role of the reticulo-endothelial cell in iron metabolism. Br J Hematol 6: 43–55, 1960

    Google Scholar 

  49. Quastel MR, Ross JF: The effect of acute inflammation on the utilization and distribution of transferrin-bound and erythrocyte radioiron. Blood 28: 738–757, 1966

    Google Scholar 

  50. Konijn AD, Hershko C: Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release. Br J Hematol 37: 7–16, 1977

    Google Scholar 

  51. Bromford AB, Munro HN: Biosynthesis of ferritin and isoferritins. In. Iron in Biochemistry and Medicine. Academic Press, New York, 1980, pp 173–202

    Google Scholar 

  52. Letendre ED, Holbein BE: Turnover in the transferrin iron pool during the hypoferremic phase of experimental Neisseria meningitidis infection in mice. Infect Immun 39: 50–59, 1983

    Google Scholar 

  53. Letendre ED, Holbein BE: Mechanism of impaired iron release by the RE system during the hypoferremic phase of experimental Neisseria meningitidis infection in mice. Infect Immun 44: 320–325, 1984

    Google Scholar 

  54. White GP, Worwood M, Parry DH, Jacobs A: Ferritin synthesis in normal and leukemic leukocytes. Nature London 250: 584–586, 1974

    Google Scholar 

  55. Glass J, Nunez MT, Fischer S, Robinson H: Transferrin receptors, iron transport and ferritin metabolism in Friend erythroleukemia cells. Biochem Biophys Acta 542: 154–162, 1978

    Google Scholar 

  56. Konijn A, Hershko C, Izak G: Ferritin synthesis in developing erythroid precursor cells. Israel J Med Sci 14: 1181–1185, 1978

    Google Scholar 

  57. Kampschmidt RF: Role of RES and LEM in iron, zinc, and copper metabolism. Adv Exp Med Biol 121A: 403–411, 1980

    Google Scholar 

  58. Kampschmidt RF: Leukocyte endogenous mediator. J Reticuloendothelial Soc 23: 287–297, 1978

    Google Scholar 

  59. Kushner I: The phenomenon of the acute phase response. Ann NY Acad Sci 389: 39–48, 1982

    Google Scholar 

  60. Butter EJ, Curtis MJ, Watford M: The effect of Escherichia coli endotoxin on the plasma iron concentration in the domestic fowl. Res Vet Sci 15: 267–269, 1973

    Google Scholar 

  61. Grieger TA, Kluger MG: Effects of bacteria and temperature on free serum iron levels in the lizard Dipsosaurus dorsalis. Physiologist 20: 37, 1977

    Google Scholar 

  62. Chandlee GC, Fukui GM: The role of endotoxin-induced non-specific protection. Abst Annu Meet Am Soc Microbiol p 45, 1965

  63. Elin RJ, Wolff SM: The role of iron in non-specific resistance to infection induced by endotoxin. J Immunol 112: 737–745, 1973

    Google Scholar 

  64. Kochan I: The role of iron in bacterial infections with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol 60: 1–30, 1973

    Google Scholar 

  65. Letendre ED, Holbein BE: Ceruloplasmin and regulation of transferrin iron during Neisseria meningitidis infection in mice. Infect Immun 45: 133–138, 1984

    Google Scholar 

  66. Baggs RB, Miller SA: Nutritional iron deficiency as a determinant of host resistance in the rat. J Nutr 103: 1554–1560, 1973

    Google Scholar 

  67. Chu SW, Welch KJ, Murray ES, Hegsted DM: Effect of iron deficiency on the susceptibility to Streptococcus pneumoniae infection in the rat. Nut Rep Int 14: 605–609, 1976

    Google Scholar 

  68. Lee CM, George YG, Aboko-Cole GF: Interaction of nutrition and infection. Int J Biochem 8: 525–529, 1977

    Google Scholar 

  69. Pushmann M, Ganzoni AM: Increased resistance of irondeficient mice to Salmonella infection. Infect Immun 17: 663–664, 1977

    Google Scholar 

  70. Murray MJ, Murray AB: Starvation suppression and refeeding: activation of infection. Lancet i: 123–125, 1977

    Google Scholar 

  71. Murray MJ, Murray MB, Murray CJ: The adverse effect of iron repletion on the course of certain infections. Br Med J ii: 1113–1115, 1978

    Google Scholar 

  72. Nauts HC: Bacterial vaccine therapy for cancer. Develop Biol Standardization 38: 487–494, 1978

    Google Scholar 

  73. Nauts HC: The apparently beneficial effects of bacterial infections on host resistance to cancer: end results in 435 cases. Cancer Res Inst Monographs 8: 1–830, 1980

    Google Scholar 

  74. Pearl R: Cancer and tuberculosis. Am J Hyg 9: 97–159, 1929

    Google Scholar 

  75. Kreider JW, Bartlett GL, Purnell DM: Immunotherapeutic effectiveness of BCG inactivated by various modalities. Cancer 46: 480–487, 1980

    Google Scholar 

  76. Yang C, Nowotny A: Effect of endotoxin on tumor resistance in mice. Infect Immun 9: 95–100

  77. Sword CP: Mechanisms of pathogenesis in Listeria monocytogenes infection. J Bact 92: 536–542, 1966

    Google Scholar 

  78. Milas L, Scott TM: Antitumor activity of Corynebacterium parvum. Adv Cancer Res 26: 257–304, 1978

    Google Scholar 

  79. Bullen JJ, Cushnie GH, Rogers HJ: The abolition of the protective effect of Clostridium welchii type A antiserum by ferric iron. Immunol 12: 303–312, 1967

    Google Scholar 

  80. Bullen JJ, Rogers HJ, Griffiths E: Role of iron in bacterial infections. Curr Top Microbiol Immunol 80: 1–35, 1978

    Google Scholar 

  81. Bullen JJ, Wards CG, Wallis SN: Virulence and the role of iron in Pseudomonas aeruginosa infection. Infect Immun 10: 443–450, 1974

    Google Scholar 

  82. Holbein BE: Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin. Infect Immun 34: 120–125, 1981

    Google Scholar 

  83. Payne SM, Finkelstein RA: Pathogenesis and immunology of experimental gonococcal infection: role of iron in virulence. Infect Immun 12: 1313–1318, 1975

    Google Scholar 

  84. Melby K, Slordahl S, Gutteberg TJ, Nordbo SA: Septicemia due to Yersinia enterolitica after oral overdoses of iron. Br Med J 285: 467–468, 1982

    Google Scholar 

  85. Holbein BE, Jericho KW, Likes GC: Neisseria meningitidis: infection in mice influence of iron, variations in virulence among strains and pathology. Infect Immun 24: 545–551, 1979

    Google Scholar 

  86. Calver GA, Kenny CP, Lavergne G: Iron as a replacement for mucin in the establishment of meningococcal infection in mice. Can J Microbiol 22: 832–838, 1976

    Google Scholar 

  87. Fusillo MH, Smith JC, Reednick JA: Iron and the mystique of mucin. Abstr Annu Meet Am Soc Microbiol p 73, 1974

  88. Bennett IL, Hook EW: Infectious diseases (some aspects of salmonellosis). Annu Rev Biochem 10: 1–20, 1959

    Google Scholar 

  89. Black PH, Kunz JJ, Swartz MN: Salmonellosis — a review of some unusual aspects. N Engl J Med 262: 811–817, 1960

    Google Scholar 

  90. Rabson AR, Hallett AF, Koornhof HJ: Generalized Yersinia enterolitica infection. J Infect Dis 131: 447–451, 1975

    Google Scholar 

  91. Scott PH, Berger HM, Scott P, Kenwood C, Wharton BA: Effect of gestational age and intrauterine nutrition on plasma transferrin and iron in the newborn. Arch Dis Child 50: 796–798, 1975

    Google Scholar 

  92. Stockman JA: Infections and iron: too much of a good thing? Am J Dis Child 135: 18–20, 1981

    Google Scholar 

  93. Farmer K, Becroft DM: Administration of parenteral iron to newborn infants. Arch Dis Child 51: 486–488, 1976

    Google Scholar 

  94. Murray MJ, Murray AB, Murray NJ, Murray MB: Refeeding malaria and hyperferremia. Lancet i: 653–654, 1975

    Google Scholar 

  95. Murray MJ, Murray AB, Murray NJ, Murray MB: Somali food shelters in the Ogadan famine and their impact on health. Lancet i: 1283–1285, 1976

    Google Scholar 

  96. Robertson MA, Harrington JS, Bradshaw E: The cancer pattern in African gold miners. Br J Cancer 25: 395–402, 1971

    Google Scholar 

  97. Berman C: Primary carcinoma of the liver. Adv Cancer Res 5: 55–96, 1958

    Google Scholar 

  98. Axelson O, Sjoberg AS: Cancer incidence and exposure to iron. Occup Med 21: 419–422, 1979

    Google Scholar 

  99. Bomford A, Williams R: Long-term results of venesection therapy in idiopathic hemochromatosis. Quart J Med 45: 611–623, 1976

    Google Scholar 

  100. Johnson PJ, Krasner N, Portmann B, Eddleston ALWF, Williams R: Hepatocellular carcinoma in Great Britain: influence of age, sex, Hb Ag status and etiology of underlying cirrhosis. Gut 19: 1022–1026

  101. Milder MS, Cook JD, Stray S, Finch CA: Idiopathic hemochromatosis, an interim report. Medicine 59: 34–49, 1980

    Google Scholar 

  102. Purtillo DT, Gottlieb LS: Cirrhosis and hepatoma occurring at Boston City Hospital (1917–1968). Cancer 32: 458–462, 1973

    Google Scholar 

  103. Sherlock S: Hemochromatosis: course and treatment. Annu Rev Med 27: 143–149, 1976

    Google Scholar 

  104. Magnusson G, Flodh H, Malmfors T: Oncological study in rats with Ferastral an iron-polycomplex, after intramuscular administration. Scand J Haematol Suppl 32: 87–98. 1977

    Google Scholar 

  105. Lundin PM: The carcinogenic action of complex iron preparations. Br J Cancer 15: 838–847

  106. Van Asbeck BS, Verbrugh HA, Van Oost BA, Marx JJM, Imhof HW, Verhoef J: Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br Med J 284: 542–544, 1982

    Google Scholar 

  107. Weinberg JB, Hibbs JB: Endocytosis of red blood cells or hemoglobin by activated macrophages inhibit their tumorcidal effect. Nature London 269: 245–247, 1977

    Google Scholar 

  108. Stich HF, Wei L, Whiting RF: Enhancement of the chromosome-damaging action of ascorbate by transition metals. Cancer Res 39: 4145–4151, 1979

    Google Scholar 

  109. Guille E, Grisvard J, Sissoeff I: Implications of reiterative DNA-metal ion complexes in the induction and development of neoplastic cells. Biol Trace Elem Res 1: 299–311

  110. Tani P: Serum iron, copper, iron-binding capacity and marrow hemosiderin in pulmonary tuberculosis. Ann Med Intern Fenn 54: Suppl. 44: 1–61, 1965

    Google Scholar 

  111. Levine AS, Schimpff SC, Graw RG, Young RC: Hematologic malignancies and other marrow failure states: progress in the management of complicating infections, Semin Hematol 11: 141–202

  112. Trowbridge IS, Domingo DL: Anti-Tf receptor monoclonal antibodies and toxin-antibody conjugates affect growth of human tumor cells. Nature 294: 171–173, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculté de Médecine, Université de Montréal, Succ. A, C.P. 6128, Montréal, Québec, Canada

    Elaine D. Letendre

  2. 4386 Marcil, H4A 2Z8, Montréal, Québec, Canada

    Elaine D. Letendre

Authors
  1. Elaine D. Letendre
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Letendre, E.D. Iron metabolism during infection and neoplasia. Cancer Metast Rev 6, 41–53 (1987). https://doi.org/10.1007/BF00047608

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00047608

Keywords

Search

Navigation